Chemotherapy and Radiotherapy for Tonsil Cancer
Author Information
Author(s): R Prestwich, K Kancherla, D Oksuz Colpan, D Williamson, K E Dyker, C Coyle, M Sen
Primary Institution: St. James's Institute of Oncology, St. James's University Hospital, Leeds Teaching Hospitals, Leeds, West Yorkshire, UK
Hypothesis
Can induction chemotherapy followed by chemoradiotherapy improve outcomes for patients with locally advanced tonsillar cancer?
Conclusion
Cisplatin-based induction and concurrent chemoradiotherapy provides excellent tumour control with acceptable toxicity for patients with locally advanced tonsillar cancer.
Supporting Evidence
- 85% of patients received 2 or more cycles of induction chemotherapy.
- 78% of patients had a clinical response after induction chemotherapy.
- 91% local and regional control rate in complete responders at 3 years.
- 75% three-year progression-free survival rate in all patients.
Takeaway
Doctors used chemotherapy and radiation to treat patients with tonsil cancer, and most of them got better without needing surgery.
Methodology
Retrospective analysis of 41 patients treated with induction chemotherapy followed by chemoradiotherapy.
Potential Biases
The study may not represent outcomes in a broader patient population as it was conducted in a single center.
Limitations
The study did not assess the prevalence of HPV in the patient cohort, which limits comparisons with other studies.
Participant Demographics
Median age was 55 years, with 68% male participants.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website